Alcresta Therapeutics
Latest round
- Series C
Last raised
- Mar 2016
Total raised
- $66M
Investors
- 5
About Alcresta Therapeutics
Founded in 2011 by Robert Gallotto and Shaheda Ahmed and based in Massachusetts, US, Alcresta Therapeutics, Inc. operates as a developer of innovative enzyme-based nutritional products that improve patient health and manage gastrointestinal disorders and rare diseases. In January 2019, Alcresta Therapeutics, Inc. The firm offers products for treating fat malabsorption due to conditions like cystic fibrosis, short bowel syndrome, pancreatitis, and other rare diseases. Their lead product, RELiZORB®, uses patented iLipase® technology to break down fats in enteral feeding formulas, facilitating easier absorption of essential fatty acids. RELiZORB is suitable for pediatric and adult patients and can be used in various care settings. Alcresta also offers additional enzyme therapies for conditions like neonatal pancreatic immaturity.
Who invested in Alcresta Therapeutics
5 investors across 3 rounds
See all investors in Alcresta Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Alcresta Therapeutics
Who invested in Alcresta Therapeutics?
Alcresta Therapeutics has 5 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Alcresta Therapeutics raised?
Alcresta Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Alcresta Therapeutics last raise money?
Alcresta Therapeutics's most recent round on record is a Series C, in Mar 2016.
What does Alcresta Therapeutics do?
Founded in 2011 by Robert Gallotto and Shaheda Ahmed and based in Massachusetts, US, Alcresta Therapeutics, Inc.
Where is Alcresta Therapeutics headquartered?
Alcresta Therapeutics is headquartered in Waltham, US.
Which VCs invest in companies like Alcresta Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Alcresta Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Alcresta Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.